Barclays PLC Regenxbio Inc. Transaction History

Barclays PLC

$436 Billion
Q2 2025

A detailed history of Barclays PLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Barclays PLC holds 239,535 shares of RGNX stock, worth $3.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

239,535

Previous 239,535 -0.0%

Holding current value

$3.03 Million

Previous $1.97 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$5.31 - $10.4 $636,541 - $1.25 Million	119,876 Added 100.18%	239,535 $1.97 Million
Q1 2025 May 15, 2025	SELL	$5.92 - $8.7 $43,843 - $64,432	-7,406 Reduced 5.83%	119,659 $855,000
Q4 2024 Feb 13, 2025	BUY	$7.23 - $11.56 $79,826 - $127,633	11,041 Added 9.52%	127,065 $982,000
Q3 2024 Nov 15, 2024	BUY	$10.49 - $14.39 $712,774 - $977,771	67,948 Added 141.33%	116,024 $1.22 Million
Q2 2024 Aug 14, 2024	SELL	$11.51 - $21.53 $15,837 - $29,625	-1,376 Reduced 2.78%	48,076 $561,000
Q1 2024 May 15, 2024	SELL	$12.17 - $24.61 $761,257 - $1.54 Million	-62,552 Reduced 55.85%	49,452 $1.04 Million
Q4 2023 Feb 15, 2024	BUY	$12.89 - $20.82 $389,239 - $628,701	30,197 Added 36.91%	112,004 $2.01 Million
Q3 2023 Nov 07, 2023	SELL	$16.46 - $19.99 $139,383 - $169,275	-8,468 Reduced 9.38%	81,807 $1.35 Million
Q2 2023 Aug 03, 2023	BUY	$17.23 - $21.71 $405,370 - $510,771	23,527 Added 35.25%	90,275 $1.8 Million
Q1 2023 May 04, 2023	SELL	$18.08 - $24.55 $539,868 - $733,063	-29,860 Reduced 30.91%	66,748 $1.26 Million
Q4 2022 Feb 13, 2023	BUY	$20.4 - $24.73 $233,845 - $283,479	11,463 Added 13.46%	96,608 $2.19 Million
Q3 2022 Nov 03, 2022	BUY	$22.29 - $35.04 $1.57 Million - $2.46 Million	70,215 Added 470.29%	85,145 $2.25 Million
Q2 2022 Aug 12, 2022	SELL	$19.35 - $35.04 $631,119 - $1.14 Million	-32,616 Reduced 68.6%	14,930 $369,000
Q1 2022 May 16, 2022	SELL	$24.62 - $34.31 $488,140 - $680,264	-19,827 Reduced 29.43%	47,546 $1.58 Million
Q4 2021 Feb 14, 2022	SELL	$30.19 - $40.28 $7,728 - $10,311	-256 Reduced 0.38%	67,373 $2.2 Million
Q3 2021 Nov 09, 2021	BUY	$29.09 - $45.68 $948,072 - $1.49 Million	32,591 Added 93.02%	67,629 $2.84 Million
Q2 2021 Aug 13, 2021	SELL	$32.46 - $40.48 $1.15 Million - $1.44 Million	-35,460 Reduced 50.3%	35,038 $1.36 Million
Q1 2021 May 13, 2021	BUY	$33.61 - $49.95 $1.01 Million - $1.5 Million	29,944 Added 73.84%	70,498 $2.41 Million
Q4 2020 Feb 11, 2021	SELL	$26.52 - $49.35 $827,821 - $1.54 Million	-31,215 Reduced 43.49%	40,554 $1.84 Million
Q3 2020 Nov 12, 2020	SELL	$27.01 - $40.26 $464,409 - $692,230	-17,194 Reduced 19.33%	71,769 $1.98 Million
Q2 2020 Aug 12, 2020	SELL	$27.75 - $43.44 $32,245 - $50,477	-1,162 Reduced 1.29%	88,963 $3.28 Million
Q1 2020 May 13, 2020	SELL	$21.5 - $54.2 $2.08 Million - $5.23 Million	-96,543 Reduced 51.72%	90,125 $2.92 Million
Q4 2019 Feb 10, 2020	BUY	$34.54 - $44.87 $4.34 Million - $5.64 Million	125,679 Added 206.07%	186,668 $7.65 Million
Q3 2019 Nov 14, 2019	SELL	$31.84 - $50.88 $232,049 - $370,813	-7,288 Reduced 10.67%	60,989 $2.17 Million
Q2 2019 Aug 14, 2019	SELL	$42.0 - $59.29 $617,484 - $871,681	-14,702 Reduced 17.72%	68,277 $3.51 Million
Q1 2019 May 15, 2019	BUY	$40.82 - $62.45 $1.96 Million - $3 Million	48,106 Added 137.95%	82,979 $4.76 Million
Q4 2018 Feb 14, 2019	BUY	$39.11 - $75.15 $44,389 - $85,295	1,135 Added 3.36%	34,873 $1.46 Million
Q3 2018 Nov 14, 2018	BUY	$65.0 - $82.15 $1.03 Million - $1.3 Million	15,860 Added 88.71%	33,738 $2.55 Million
Q2 2018 Aug 14, 2018	SELL	$27.2 - $74.35 $71,726 - $196,060	-2,637 Reduced 12.85%	17,878 $1.28 Million
Q1 2018 May 15, 2018	BUY	$24.05 - $37.5 $116,329 - $181,387	4,837 Added 30.85%	20,515 $614,000
Q4 2017 Feb 14, 2018	BUY	$26.0 - $34.6 $86,242 - $114,768	3,317 Added 26.83%	15,678 $521,000
Q3 2017 Nov 14, 2017	BUY	$18.0 - $32.95 $222,498 - $407,294	12,361	12,361 $407,000

Others Institutions Holding RGNX

# of Institutions

183

Shares Held

45.3M

Call Options Held

103K

Put Options Held

100K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $546M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account